KALUGA, June 5. /TASS/. A new pharmaceutical plant, Nearmedic Pharma, located on the territory of a major innovation and industrial Kaluga region, in central Russia, is starting manufacturing medicines.
The project worth $73 million is implemented in cooperation with the national holding company Nearmedic and the Russian Corporation of Nanotechnologies, the press service of Nearmedic Plus told TASS.
The new plant complies with international standards GMP, ISO and FDA. The total annual output reaches up to 100 million medical products, including anti-viral medications.
"The plant is unique as the whole cycle from the synthesis of incoming substances to manufacturing of finished pharma products comes in the framework of one production unit and the product range is the company’s innovations," the press service said.
All the pharmaceutical companies in Russia's Kaluga region are united in a single pharma cluster which now consists of 54 companies.